It appears our best hope is for KB to step forward and also to recruit someone with expertise in the pharmaceutical field. I hope the perceived "connections" are a reality or this is looking much dicier. I am concerned that info flow has been lacking and suspect there is a reason for it, and it is NOT the shareholder base!!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.